Indaptus Therapeutics is trading at $3.56, a -11.00% move, with no clear company-specific announcement explaining the September 25, 2026 decline. - The previously announced $24.0 million private placement involving 20,338,974 shares dates to September 8 and is not a new event today. - Broader markets are higher, so overall market direction does not explain the decline. - Continued volatility and trading dynamics may be contributing, but the specific catalyst remains unclear.